The Infinion Biopharma Ltd Date Will Be Updated Soon. Read the post to learn about Infinion Biopharma Ltd IPO GMP.
Infinion Biopharma Ltd IPO is a pharmaceutical licencing and commercialization firm specialising in high-value, innovative medications across many therapeutic categories. The business has filed an IPO prospectus to generate an unknown sum by selling 45 lakh equity shares.
Infinion Biopharma is a research-driven life sciences company that develops innovative and valuable medications for various therapeutic uses by combining traditional pharmacology with biochemistry, biophysics, and engineering. By becoming a global biopharmaceutical leader, we hope to enhance patient lives everywhere.
Everyone should have access to high-quality drugs, whether needed for illness treatment, infection prevention, or improving overall health. This sums up the values that govern our business dealings and methods of providing healthcare.
Start your investing journey today. Find the latest information on Upcoming IPOs.
Key Details Of Infinion Biopharma Ltd IPO:
Bidding Dates
Coming Soon
Price Range
₹0 per share
Face Value
₹0 per share
GMP
₹0
Infinion Biopharma Ltd IPO GMP
The Infinion Biopharma Ltd IPO GMP Today is ₹0.
IPO Overview
Infinion Biopharma has submitted initial share sale documents to Sebi to generate money. 45 lakh equity shares with a face value of Rs. 10 are sold in the initial public offering (IPO). The corporation may consider A pre-IPO placement of up to 7 lakh equity shares.
The Infinion Biopharma Ltd IPO GMP Today is ₹0. They have established critical commercial ties with several pharmaceutical businesses in the US and the UK to conduct research, design, and develop various medicinal goods.
Infinion Biopharma Ltd IPO Financials
Particulars | FY21 | FY20 | FY19 |
Total Income | 68,987.06 | NA | NA |
EBITDA | NA | NA | NA |
EBITDA Margin (%) | NA | NA | NA |
Profit After Tax | 64,240.27 | 13,697.46 | 3,635.15 |
EPS | 6.24 | 1.71 | 0.66 |
ROE | NA | NA | NA |
Company Profile
Infinion Biopharma specialises in pharmaceutical licencing and commercialising high-value, novel pharmaceuticals across several therapeutic categories. The business has submitted an IPO prospectus to raise an unknown sum by selling 45 lakh equity shares. Research-focused Infinion Biopharma is a life science business that licences and sells a range of medicinal products. They work on cutting-edge technology development that combines conventional pharmacology and biochemistry with biophysics and engineering to create high-value, cutting-edge goods. It has produced a diverse range of scientific fields around the globe, including biophysics, biochemistry, pharmacology and biotechnology, to create
novel products to control and cure various illnesses. Innovative life sciences business Infinion Biopharma creates high-value, novel therapeutics in various therapeutic areas by fusing classical pharmacology and biochemistry with biophysics and engineering.
IPO Strengths
- Experienced promoters and a competent management team.
- Well-established relationships with a loyal customer base.
- Access to markets worldwide, enabling global reach.
IPO Weakness
- Customers from the United States are heavily relied on.
- To guarantee compliance, one must abide by several rules and regulations in these nations.
- Competition from other players in the market.
Infinion Biopharma Ltd FAQs
When will Infinion Biopharma Ltd. IPO allotment be available?
Details not available.
What will be Infinion Biopharma Ltd. IPO lot size?
Details not available.
When will Infinion Biopharma Ltd. IPO open for subscription?
Details not available.
What minimum lot size can retail investors subscribe to?
Retail investors can apply for a minimum of one lot.
When will Infinion Biopharma Ltd. list on exchanges?
It usually takes ten working days from the last day of subscription to list the IPO on the bourses.
How to check the allotment status of Infinion Biopharma Ltd. IPO?
Angel One customers can log in to their accounts to check Infinion Biopharma Ltd. IPO allotment status.
When checking the allotment status, keep your application, DP ID, and PAN number ready.
What would be the listing gains on Infinion Biopharma Ltd. IPO?
Listing gain is the difference between the IPO’s opening and offer prices.
The listing gain results from changing investors’ interests, global parameters, and short vs long-term outlooks.
I have finished the application process for Infinion Biopharma Ltd. IPO, but the funds are not yet debited. What is the reason?
The bank initially blocks the amount you bid for an IPO. It will debit the amount when the shares get allotted or unblock it after the UPI mandate expiry date.
How to approve the UPI mandate request for Infinion Biopharma Ltd. IPO?
Login to your UPI handle and approve the payment mandate to complete the IPO application process.
Can I submit more than one application for the public issue of Infinion Biopharma Ltd. using one PAN?
You can submit only one application using one PAN card.
What is the minimum order quantity for Infinion Biopharma Ltd. IPO?
The minimum size of the application will be one lot.
Leave a Reply